FDA Warns Bayer Over Aspirin Product Claims

October 29, 2008

The Food and Drug Administration has sent warning letters to Bayer claiming the company never submitted proof that its Women’s Low Dose Aspirin + Calcium and Bayer Aspirin with Health Advantage are effective in treating heart disease or osteoporosis.

Recent News